The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2022
Filed:
Dec. 09, 2020
Applicants:
The Regents of the University of California, Oakland, CA (US);
Shanghai Chempartner Co., Ltd., South San Francisco, CA (US);
Inventors:
Dean Sheppard, Oakland, CA (US);
William F. DeGrado, San Francisco, CA (US);
Hyunil Jo, Lafayette, CA (US);
Aparna Sundaram, San Francisco, CA (US);
Richard Beresis, San Francisco, CA (US);
Assignees:
The Regents of the University of California, Oakland, CA (US);
Shanghai ChemPartner Co., Ltd., South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07C 279/18 (2006.01); C07C 279/28 (2006.01); C07C 317/14 (2006.01); C07D 239/14 (2006.01); C07D 265/08 (2006.01); C07D 265/16 (2006.01); C07D 265/36 (2006.01); C07D 295/155 (2006.01); C07D 311/68 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); A61K 31/337 (2006.01); A61K 31/704 (2006.01); C07D 235/16 (2006.01); C07D 213/74 (2006.01); C07D 233/88 (2006.01); C07D 215/42 (2006.01); C07D 279/06 (2006.01);
U.S. Cl.
CPC ...
C07C 279/18 (2013.01); C07C 279/28 (2013.01); C07C 317/14 (2013.01); C07D 213/74 (2013.01); C07D 215/42 (2013.01); C07D 233/88 (2013.01); C07D 235/16 (2013.01); C07D 239/14 (2013.01); C07D 265/08 (2013.01); C07D 265/36 (2013.01); C07D 279/06 (2013.01); C07D 295/155 (2013.01); C07D 311/68 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07C 2601/16 (2017.05);
Abstract
The disclosure provides, inter alia, alpha-5 beta-1 inhibitors, pharmaceutical compositions comprising alpha-5 beta-1 inhibitors, methods for treating diseases using alpha-5 beta-1 inhibitors, and processes for making alpha-5 beta-1 inhibitors.